2024

https://www.google.com/url?sa=i&url=https%3A%2F%2Fhealth.economictimes.indiatimes.com%2Fnews%2Fpharma%2Fbeta-drugs-limited-expands-portfolio-with-bevacizumab-adcimib-and-trastuzumab-vicentra-biosimilars%2F101802349&psig=AOvVaw01VYQUTQSmD1R0VxVyRsMl&ust=1719755907845000&source=images&cd=vfe&opi=89978449&ved=0CBEQjRxqFwoTCNCU1bj8gIcDFQAAAAAdAAAAABAE

Bevacizumab and Trastuzumab Biosimilars Case Continues, With No End in Sight  

/ By / Patent

The Indian pharmaceutical landscape has seen the emergence of biosimilars like Bevacizumab and Trastuzumab (used as first-line treatment of advanced HER2-positive gastric cancer) commanding a market worth around 640 crores. In this (delayed yet relevant) post, we will discuss the bizarre ongoing Trastuzumab and Bevacizumab litigation before the DHC, focussing on the September 11, 2023 joint judgement passed in two connected cases (Roche versus DCGI, and versus Cadila, respectively). It is bizarre because Roche is exerting rights with respect to […]

Bevacizumab and Trastuzumab Biosimilars Case Continues, With No End in Sight   Read More »

https://www.google.com/url?sa=i&url=https%3A%2F%2Fwww.livelaw.in%2Ftop-stories%2Fbombay-high-court-covid-19-covaxin-clinical-trial-saket-gokhale-168466&psig=AOvVaw0gaz6Xv_YYDh5Akx0gowP4&ust=1719754816659000&source=images&cd=vfe&opi=89978449&ved=0CBQQjhxqFwoTCMDvg5X4gIcDFQAAAAAdAAAAABAE

What’s in a Missing Name? Some Questions Around the Covaxin Patent Application

/ By / Patent

[A big thanks to Swaraj for his inputs on the post.] The Exclusion of ICMR from the Patent Application Last weekend, a series of unusual developments regarding the Covaxin patent (Patent Application Number: 202041007559) generated significant buzz. Notably, in The Hindu, Jacob Koshy published back-to-back articles, with the first one appearing on June 22, 2024 (read here (paywalled)). In this article, Koshy reveals that Bharat Biotech (BBIL) filed a patent application for Covaxin without listing the Indian Council of Medical

What’s in a Missing Name? Some Questions Around the Covaxin Patent Application Read More »

Prof. Avichal Bhatnagar v. The CEO, Pralek Prakashan Pvt. Ltd : Taking a Look at The Conundrum Surrounding Copyright Protection vis-a-vis Accessibility for PwDs

/ By / Copyright

In light of the recent order of the Office of Chief Commissioner for Persons with Disabilities in Avichal Bhatnagar v. Pralek Prakashan we are pleased to bring to you this guest post by Lakshita Handa and Pragya Singh. Emphasizing the lack of a robust mechanism to ensure access to literary work by persons with disability, the authors highlight how the existing copyright framework comes in conflict with the rights enshrined under the Rights of Persons with Disabilities Act, 2016. Lakshita

Prof. Avichal Bhatnagar v. The CEO, Pralek Prakashan Pvt. Ltd : Taking a Look at The Conundrum Surrounding Copyright Protection vis-a-vis Accessibility for PwDs Read More »

Some Thoughts on the Bombay High Court Order in Pidilite v. Astral Design Infringement Case

/ By / Design

On the recent decision dt. June 13, by the Bombay High Court in Pidilite Limited v. Astral Industries, we are pleased to bring to you this post by SpicyIP intern Aarav Gupta, discussing the Court’s finding on mosaicing and highlighting the lack of three factor assessment for interim injunctions. Aarav is a third-year law student at National Law University, Delhi. He is passionate about geopolitics, foreign policy, international trade, and intellectual property and spends his time reading and watching sports.

Some Thoughts on the Bombay High Court Order in Pidilite v. Astral Design Infringement Case Read More »

Parties Settle the Tips v. Wynk Copyright Dispute: Wynk, Wink, and a 12 Crore Nod!

/ By / Copyright

On June 18 Bombay High Court passed an order noting the consent terms between the parties in Tips v. Wynk copyright dispute. Discussing what the dispute was all about and highlighting the importance of the previous orders especially in the context of application of Section 31D vis a vis streaming, we are pleased to bring to you this post by SpicyIP intern Aditya Bhargava. Aditya is a second-year law student at NLSIU Bangalore. He is interested in intellectual property, AI

Parties Settle the Tips v. Wynk Copyright Dispute: Wynk, Wink, and a 12 Crore Nod! Read More »

[Sponsored] AI Searches get 33% Better with the New PatSeer’s AI Search v2 Engine

/ By / Patent

We are pleased to bring to you this sponsored post by PatSeer on the launch of their AI search V2. For more details, read on below. AI Searches get 33% Better with the New PatSeer’s AI Search v2 Engine Exactly one year ago, PatSeer launched its AI search for patents by introducing a completely new search powered by a custom-trained LLM model. Today I am excited to announce AI Search v2 which is a significant upgrade to the underlying AI

[Sponsored] AI Searches get 33% Better with the New PatSeer’s AI Search v2 Engine Read More »

Karnataka High Court Forms a Sub-Committee to Draft IPD Rules

/ By / Copyright, Design, Geographical Indication, Patent, Plant Variety Protection, Trademark

In an important development, the Karnataka High Court on June 20 released a notification forming a sub-committee to draft rules for establishing an IP Division. The sub-committee comprises Registrar (Judicial), Karnataka High Court (the position is presently held by Mr. E. Rajeeva Gowda)  and Prof. Dr. Arul Scaria, Associate Professor, NLSIU, Bangalore. With this, the Karnataka High Court seems to be the latest High Court on its way to establish a dedicated IP Division. In the gamut of high courts,

Karnataka High Court Forms a Sub-Committee to Draft IPD Rules Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (June 17-June 23)

/ By / Copyright, Patent, Trademark

Here is our recap of last week’s top IP developments including summary of the post on the writs against the recent Patent Examiner recruitments, Delhi High Court decisions in the Under Armour case, the InterDigital-Xiaomi SEP litigation, and the Court’s ex-parte interim injunctions in the “Aap ki Adalat” case. Anything we are missing out on, feel free to drop a comment and let us know. Highlights of the Week Irregularities in the Patent Examiner Recruitment Exams? DHC to Decide on the

SpicyIP Weekly Review (June 17-June 23) Read More »

An Assessment of the National Policy on Research & Development and Innovation in the Pharma-Med Tech Sector in India

/ By / Patent

On the National Policy on Research & Development and Innovation in the Pharma-Med Tech Sector in India and its implementing scheme, we are pleased to have this post by Pranav Aggarwal, discussing the crucial aspects of this policy and scheme and highlighting their shortcomings. Though the post is a bit dated and was pending from our end for a while, its extremely important especially in the light of the discourse over public-private collaboration in the pharma sector. Pranav is a

An Assessment of the National Policy on Research & Development and Innovation in the Pharma-Med Tech Sector in India Read More »

Rethinking Initial Interest Confusion And Consumer Sophistication In The Digital Age: Unarmouring The Under Armour At The DHC

/ By / Trademark

Following the discussion on the DHC’s finding in the Forest Essentials case, we are pleased to bring to you another post by SpicyIP intern Aditya Bhargava, revisiting initial interest confusion and consumer sophistication in light of the DHC’s recent Under Armour decision. Aditya is a second-year law student at NLSIU Bangalore. He is interested in intellectual property, AI regulation and tech law. His previous posts can be accessed here. Rethinking Initial Interest Confusion And Consumer Sophistication In The Digital Age: Unarmouring

Rethinking Initial Interest Confusion And Consumer Sophistication In The Digital Age: Unarmouring The Under Armour At The DHC Read More »

Scroll to Top